Defining the impact of platelet-to-lymphocyte ratio on patient survival with gastric neuroendocrine neoplasm: a retrospective cohort analysis

• Published in: World journal of surgical oncology Vol. 20; no. 1; pp. 1 - 356
• Main Authors: Liang, Wenquan, Xu, Xinxin, Liu, Yuhua, Cui, Jianxin, Gao, Yunhe, Wang, Chuang, Zhuang, Ziwei, Zhang, Kecheng, Xi, Hongqing, Cai, Aizhen, Wei, Bo, Chen, Lin
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 09.11.2022; BioMed Central; BMC
• Subjects: Analysis; Biological markers; Biomarker; Blood; Blood platelets; Body mass; Body mass index; Body size; Cancer; Cohort analysis; Continuity (mathematics); Endoscopy; Gastric neuroendocrine neoplasm; Gastrointestinal tumors; Health aspects; Hematology; Hospitals; Lymphocytes; Measurement; Medical examination; Medical prognosis; Mortality; Multiple regression analysis; Neoplasms; Neuroendocrine tumors; Obesity; Oncology, Experimental; Pathology; Patient outcomes; Patients; Platelet-to-lymphocyte ratio; Platelets; Prognosis; Purpura; Risk; Subgroups; Surgery; Survival; Survival analysis; Tumors; Variables; China; United States > US
• DOI: 10.1186/s12957-022-02822-9
• ISSN: 1477-7819

Background Gastric neuroendocrine neoplasm (g-NEN) is a rare but heterogeneous neoplasm, with an increasing incidence yearly. Conventional prognostic markers of g-NEN remain limited which could only be detected after surgery. There is an urgent need to explore new prognostic markers for g-NEN patients. This study aimed to investigate the prognostic value of platelet-to-lymphocyte, ratio (PLR) and the association between PLR and body mass index (BMI) in patients with gastric neuroendocrine neoplasms (g-NEN). Methods A retrospective cohort of patients with g-NEN from January 2001 through June 2016 was examined. The prognostic significance of PLR was determined by multiple regression analysis in different models. Stratified analysis was performed to examine the prognostic value of PLR at different BMI levels. Results In total, 238 patients were enrolled. Those with higher PLRs tended to undergo open surgery, had larger tumor sizes, were diagnosed more frequently with neuroendocrine carcinoma, and had higher tumor grades. PLR was significantly associated with the survival of patients with g-NEN. With PLR increased per standard deviation, the all-cause mortality risk of patients with g-NEN increased by 67%, 63%, and 54% in the crude (HR = 1.67, 95% CI 1.32-2.12, P < 0.001), minimally adjusted (HR = 1.63, 95% CI 1.28-2.08, P < 0.001), and fully adjusted (HR = 1.54, 95% CI 1.202-1.98, P = 0.001) models, respectively. Patients with higher PLR (quartile 4, [greater than or equal to] 187) had a 1.8-fold increase in all-cause mortality risk compared with those with lower PLR (quartile 1-3, < 187). Furthermore, there was a significant interaction effect between BMI subgroups and PLR in predicting the survival of patients with g-NEN (PLR regarded as a continuous variable: all P for interaction < 0.05 in the crude, minimally adjusted, and fully adjusted models; PLR regarded as a categorical variable: P for interaction < 0.05 in the fully adjusted model). Patients with g-NEN with the characteristics of higher PLR (quartile 4, [greater than or equal to] 187) and non-obesity (BMI < 25 kg/m.sup.2) had worse survival than others (P < 0.05). Conclusion The inflammation marker PLR has an independent prognostic value for patients with g-NENs, and high PLR combined with non-obesity increases the mortality risk of these patients. Keywords: Gastric neuroendocrine neoplasm, Platelet-to-lymphocyte ratio, Body mass index, Biomarker, Prognosis